Vera Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: VERA · Form: 8-K · Filed: May 19, 2025 · CIK: 1831828
| Field | Detail |
|---|---|
| Company | Vera Therapeutics, INC. (VERA) |
| Form Type | 8-K |
| Filed Date | May 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
TL;DR
Vera Therapeutics held a shareholder vote on May 14th, details filed today.
AI Summary
Vera Therapeutics, Inc. filed an 8-K on May 19, 2025, reporting on matters submitted to a vote of security holders on May 14, 2025. The filing details the company's corporate information, including its principal executive offices in Brisbane, California, and its standard industrial classification in Pharmaceutical Preparations.
Why It Matters
This filing indicates that Vera Therapeutics held a vote of its security holders, which could pertain to significant corporate decisions or governance changes.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote and does not contain information about significant financial events or operational changes.
Key Players & Entities
- Vera Therapeutics, Inc. (company) — Registrant
- May 14, 2025 (date) — Date of earliest event reported
- May 19, 2025 (date) — Date of report
- 2000 Sierra Point Parkway, Suite 1200, Brisbane, California 94005 (location) — Principal executive offices
FAQ
What specific matters were submitted to a vote of Vera Therapeutics' security holders on May 14, 2025?
The filing states that matters were submitted to a vote of security holders on May 14, 2025, but does not specify the exact nature of these matters in the provided text.
When was Vera Therapeutics, Inc. incorporated?
Vera Therapeutics, Inc. was incorporated in Delaware, as indicated by the filing.
What is Vera Therapeutics' primary business classification?
Vera Therapeutics, Inc. is classified under Pharmaceutical Preparations [2834].
What is the SEC file number for Vera Therapeutics?
The SEC file number for Vera Therapeutics is 001-40407.
Where are Vera Therapeutics' principal executive offices located?
Vera Therapeutics' principal executive offices are located at 2000 Sierra Point Parkway, Suite 1200, Brisbane, California 94005.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 19, 2025 regarding Vera Therapeutics, Inc. (VERA).